Literature DB >> 33299825

The role of associating liver partition and portal vein ligation for staged hepatectomy in the management of patients with colorectal liver metastasis.

Juan Glinka1, Victoria Ardiles1, Juan Pekolj1, Eduardo de Santibañes1, Martin de Santibañes1.   

Abstract

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) approach emerged as a promising surgical strategy for rapid and large hypertrophy of the future liver remnant (FLR) when a major liver resection is necessary. Colorectal liver metastasis (CRLM) is their main indication. However, the promising results published so far, are very difficult to interpret since they usually focus on the technique and not on the underlying disease. Moreover, they are usually made up of complex populations, which received different chemotherapy schemes, with the ALPPS technical variations implemented over time and without consistent long-term follow-up results as well. Whereby, its role in CRLM should be analyzed as carefully as possible to indicate and select the best candidates who will benefit the most from this approach. We conducted a computerized search using PubMed and Google Scholar for reports published so far, using mesh headings and keywords related to the ALPPS and CRLM. 2020 Hepatobiliary Surgery and Nutrition. All rights reserved.

Entities:  

Keywords:  Liver resection; associating liver partition and portal vein ligation for staged hepatectomy (ALPPS); colorectal cancer; liver regeneration; metastasis

Year:  2020        PMID: 33299825      PMCID: PMC7720062          DOI: 10.21037/hbsn.2019.08.03

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  68 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Totally Laparoscopic Mini-ALPPS Using a Novel Approach of Laparoscopic-Assisted Transmesenteric Portal Vein Embolization.

Authors:  Juan Pekolj; Fernando A Alvarez; David Biagiola; Lucas Villegas; Victoria Ardiles; Eduardo de Santibañes
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2018-04-16       Impact factor: 1.878

3.  Intermediate-term survival and quality of life outcomes in patients with advanced colorectal liver metastases undergoing associating liver partition and portal vein ligation for staged hepatectomy.

Authors:  Kerollos Nashat Wanis; Victoria Ardiles; Fernando A Alvarez; Mauro Enrique Tun-Abraham; David Linehan; Eduardo de Santibañes; Roberto Hernandez-Alejandro
Journal:  Surgery       Date:  2017-12-06       Impact factor: 3.982

4.  Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function.

Authors:  Boris Guiu; François Quenet; Laure Escal; Frédéric Bibeau; Lauranne Piron; Philippe Rouanet; Jean-Michel Fabre; Eric Jacquet; Alban Denys; Pierre-Olivier Kotzki; Daniel Verzilli; Emmanuel Deshayes
Journal:  Eur Radiol       Date:  2017-01-18       Impact factor: 5.315

Review 5.  Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy.

Authors:  Erik Schadde; Andreas A Schnitzbauer; Christoph Tschuor; Dimitri A Raptis; Wolf O Bechstein; Pierre-Alain Clavien
Journal:  Ann Surg Oncol       Date:  2014-12-02       Impact factor: 5.344

6.  Interstage Assessment of Remnant Liver Function in ALPPS Using Hepatobiliary Scintigraphy: Prediction of Posthepatectomy Liver Failure and Introduction of the HIBA Index.

Authors:  Matteo Serenari; Carlos Collaud; Fernando A Alvarez; Martin de Santibañes; Diego Giunta; Juan Pekolj; Victoria Ardiles; Eduardo de Santibañes
Journal:  Ann Surg       Date:  2018-06       Impact factor: 12.969

7.  ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis.

Authors:  Erik Schadde; Victoria Ardiles; Ksenija Slankamenac; Christoph Tschuor; Gregory Sergeant; Nadja Amacker; Janine Baumgart; Kris Croome; Roberto Hernandez-Alejandro; Hauke Lang; Eduardo de Santibaňes; Pierre-Alain Clavien
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

8.  Determinants of survival in liver resection for colorectal secondaries.

Authors:  H Ekberg; K G Tranberg; R Andersson; C Lundstedt; I Hägerstrand; J Ranstam; S Bengmark
Journal:  Br J Surg       Date:  1986-09       Impact factor: 6.939

9.  Prediction of Mortality After ALPPS Stage-1: An Analysis of 320 Patients From the International ALPPS Registry.

Authors:  Erik Schadde; Dimitri Aristotle Raptis; Andreas A Schnitzbauer; Victoria Ardiles; Christoph Tschuor; Mickaël Lesurtel; Eddie K Abdalla; Roberto Hernandez-Alejandro; Elio Jovine; Marcel Machado; Massimo Malago; Ricardo Robles-Campos; Henrik Petrowsky; Eduardo De Santibanes; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2015-11       Impact factor: 12.969

Review 10.  Associating liver partition and portal vein ligation for staged hepatectomy versus conventional two-stage hepatectomy: a systematic review and meta-analysis.

Authors:  Zheng Zhou; Mingxing Xu; Nan Lin; Chuzhi Pan; Boxuan Zhou; Yuesi Zhong; Ruiyun Xu
Journal:  World J Surg Oncol       Date:  2017-12-19       Impact factor: 2.754

View more
  3 in total

1.  Surgery is the means of treatment, but high-quality survival is the ultimate goal.

Authors:  Penglei Ge; Yang Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

2.  The potential role of associating liver partition and portal vein ligation in the treatment of colorectal liver metastases.

Authors:  Jan P Jonas; Henrik Petrowsky
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

3.  The Role of Farnesoid X Receptor in Accelerated Liver Regeneration in Rats Subjected to ALPPS.

Authors:  Noemi Daradics; Pim B Olthof; Andras Budai; Michal Heger; Thomas M van Gulik; Andras Fulop; Attila Szijarto
Journal:  Curr Oncol       Date:  2021-12-09       Impact factor: 3.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.